FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Luis Ruiz del Arbol

Research Profile

Disorders

Anatomy

Concepts & Ideas

Treatment Outcome

Procedures

Chemicals & Drugs

Physiology

Splanchnic Circulation

Co-author Network

Publications

TOP 3
Alessandro Principe; Pedro Melgar-Lesmes; Guillermo Fernández-Varo; Luis Ruiz del Arbol; Josefa Ros; Manuel Morales-Ruiz; Mauro Bernardi; Vicente Arroyo; Wladimiro Jiménez
The hepatic apelin system: a new therapeutic target for liver disease.
Pere Ginès; Florence Wong; hugh watson; Slobodan Milutinovic; Luis Ruiz del Arbol; Dan Olteanu
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
Pere Ginès; Juan Uriz; Blas Calahorra; Guadalupe Garcia-Tsao; Patrick S Kamath; Luis Ruiz del Arbol; Ramon Planas; Jaime Bosch; Vicente Arroyo; Juan Rodés
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Luis Ruiz del Arbol (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Alessandro Principe; Pedro Melgar-Lesmes; Guillermo Fernández-Varo; Luis Ruiz del Arbol; Josefa Ros; Manuel Morales-Ruiz; Mauro Bernardi; Vicente Arroyo; Wladimiro Jiménez
The hepatic apelin system: a new therapeutic target for liver disease.
Hepatology (Baltimore, Md.) 2008;48(4):1193-201.
2008: Pere Ginès; Florence Wong; hugh watson; Slobodan Milutinovic; Luis Ruiz del Arbol; Dan Olteanu
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
Hepatology (Baltimore, Md.) 2008;48(1):204-13.
2002: Pere Ginès; Juan Uriz; Blas Calahorra; Guadalupe Garcia-Tsao; Patrick S Kamath; Luis Ruiz del Arbol; Ramon Planas; Jaime Bosch; Vicente Arroyo; Juan Rodés
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Gastroenterology 2002;123(6):1839-47.
2002: Elena Peña Gonzalez; Luis Gil-Grande; Luis Ruiz del Arbol; David del Pozo; Joaquin Miquel; Manuel Vazquez; Antonio Garcia-Plaza; Rogelio Lopez-Velez; Antonio Retamar
Presinusoidal portal hypertension secondary to portal invasive echinococcosis.
Journal of clinical gastroenterology 2002;34(1):103-4.
2001: Juan González-Abraldes; Agustín Albillos; Rafael Bañares; Luis Ruiz del Arbol; Eduardo Moitinho; C Rodríguez; M González; Angels Escorsell; Juan Carlos García-Pagán; Jaime Bosch
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.
Gastroenterology 2001;121(2):382-8.
1998: Angels Escorsell; Josep Bordas; Luis Ruiz del Arbol; J L Jaramillo; Ramon Planas; Rafael Bañares; Agustín Albillos; Jaime Bosch
Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.
Journal of hepatology 1998;29(5):779-88.